Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Recursion Pharmaceuticals (NasdaqGS:RXRX) reports positive clinical proof of concept for REC ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

SandR is a utility for recursive search and replace operations on text files in Windows using regular expressions. SandR Recursive Search and Replace Utility SandR is a software utility designed for ...

JAKARTA, Indonesia — A predawn landslide triggered by torrential rains on Indonesia's main island of Java killed at least eight people on Saturday and left 82 missing as rescuers struggled through ...

Abstract: Narrow passage scenarios pose significant challenges for path planning, especially for tasks requiring real-time performance. Traditional asymptotically converging sampling-based planners ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Christopher Gibson, Chief Executive Officer of Recursion Pharmaceuticals, recently sold a significant chunk of his company's common stock. The CEO of Recursion Pharmaceuticals recently disposed of 120 ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...